IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This research will be conducted to see if the oral drug Cambia is as effective in relieving
severe migraine headaches as the injectable drug ketorolac.